本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aura Biosciences, Inc.

5.80
+0.830016.70%
成交量:30.38萬
成交額:170.30萬
市值:2.92億
市盈率:-3.31
高:5.82
開:4.96
低:4.95
收:4.97
資料載入中...
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/04

重要事件披露

8-K - Current report
2023/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

重要事件披露

8-K - Current report
2023/02/16

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/06

重要事件披露

8-K - Current report
2022/12/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership